CXCR1 and ovarian cancer: A large number of studies have shown that the ligand IL-8 of CXCR1/CXCR2 is abnormally increased in the plasma of patients with ovarian malignant tumors and is positively correlated with the clinical stage and pathological type of epithelial ovarian tumor (EOC) [25, 26].